Tariq Musa's Securities Transactions in Guardant Health, Inc.

Tariq Musa, a director at Guardant Health, Inc., has filed a Form 144 notice indicating the intent to sell 116 shares of common stock acquired through a restricted stock lapse. The shares were acquired on October 15, 2025, and the notice was filed on October 17, 2025. The plan for these securities was adopted on September 11, 2024. The aggregate market value of the shares to be sold is approximately $7,766.00. Additionally, Musa has sold 116 shares in each of the past three months, with gross proceeds of $5,591.00 in July 2025, $6,846.00 in August 2025, and $6,453.00 in September 2025. The transactions were executed through Charles Schwab & Co., Inc.